In the latest trading session, 380.88 million Eterna Therapeutics Inc (NASDAQ:ERNA) shares changed hands as the company’s beta touched 4.33. With the company’s most recent per share price at $0.87 changing hands around $0.56 or 182.85% at last look, the market valuation stands at $44.89M. ERNA’s current price is a discount, trading about -201.15% off its 52-week high of $2.62. The share price had its 52-week low at $0.22, which suggests the last value was 74.71% up since then. When we look at Eterna Therapeutics Inc’s average trading volume, we note the 10-day average is 0.92 million shares, with the 3-month average coming to 886.37K.

Eterna Therapeutics Inc (NASDAQ:ERNA) trade information

Instantly ERNA is in green as seen in intraday trades today. With action 165.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 197.29%, with the 5-day performance at 165.02% in the green. However, in the 30-day time frame, Eterna Therapeutics Inc (NASDAQ:ERNA) is 169.84% up. Looking at the short shares, we see there were 44458.0 shares sold at short interest cover period of 1.07 days.

Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 336.35% of Eterna Therapeutics Inc shares while 11.00% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at -4.65%.

Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 26.1 shares estimated at $21393.0 under it, the former controlled 0.05% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.03% of the shares, roughly 13.1 shares worth around $10735.0.